Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers

Journal of Psychopharmacology

Volumn 23, Issue 7, 2009, Pages 831-840

  Antypa, N ^a   Van Der Does, A J W ^a   Smelt, A H M ^b   Rogers, R D ^c  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cognition; Decision making; Depression; Mood; Omega 3 fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO;

ADULT; ARTICLE; ATTENTION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DEPRESSION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EMOTION; FACIAL EXPRESSION; FEMALE; HUMAN; IMPULSIVENESS; MALE; MEMORY; MOOD; NORMAL HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AFFECT; COGNITION; DECISION MAKING; DEPRESSION; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

EID: 69049088000     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108092120     Document Type: Article

References (44)

1. Appleton KM. Hayward RC. Gunnell D. Peters TJ. Rogers PJ. Kessler D. (2007) Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr 84: 1308-1316.
2. Attenburrow MJ. Williams C. Odontiadis J. Reed A. Powell J. Cowen PJ. (2003) Acute administration of nutritionally sourced tryptophan increases fear recognition. Psychopharmacology 169: 104-107.
3. Austin MP. Mitchell P. Goodwin GM. (2001) Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 178: 200-206.
4. Beck AT. Steer RA. Garbin MG. (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8: 77-100.
5. Booij L. Van der Does AJW. (2007) Cognitive and serotonergic vulnerability to depression: convergent findings. J Abnorm Psychol 116: 86-94.
6. Browning M. Reid C. Cowen PJ. Goodwin GM. Harmer CJ. (2007) A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol 21: 684-690.
7. Carver CS. White TL. (1994) Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: the BIS/BAS scales. J Pers Soc Psychol 67: 319-333.
8. Chalon S. (2006) Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 75: 259-269.
9. De la Presa OS. Innis SM. (1999) Docosahexaenoic acid and arachidonic acid prevent a decrease in dopaminergic and serotonergic neurotransmitters in frontal cortex caused by a-linoleic and alpha-linolenic acid deficiënt diet in formula-fed piglets. J Nutr 129: 2088-2093.
10. Ekman P. Friesen WV. (1976) Measuring facial movement. Environ Psychol Nonverbal Behav 1: 56-75.
11. Fontani G. Corradeschi F. Felici A. Alfatti F. Migliorini S. Lodi L. (2005) Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 35: 691-699.
12. Freeman MP. (2000) Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry 12: 159-165.
13. Freeman PM. Hibbeln JR. Wisner KL. Davis JM. Mischoulon D. Peet M. Keck PE. Marangell LB. Richardson AJ. Lake J. Stoll AL. (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67: 1954-1967.
14. Hallahan B. Garland MR. (2004) Essential fatty acids and their role in the treatment of impulsivity. Prostaglandins Leukot Essent Fatty Acids 71: 211-216.
15. Hamazaki T. Sawazaki S. Kobayashi M. (1996) The effect of docasahexaenoic acid on aggression in young adults. A double-blind study. J Clin Invest 97: 1129-1134.
16. Harmer CJ. Bhagwagar Z. Perrett DI. Volm BA. Cowen PI. Goodwin GM. (2003) Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28: 148-152.
17. Hibbeln JR. Linnoila M. Umhau JC. Rawlings R. George DT. Salem N. (1998) Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects and early- and late-onset alcoholics. Biol Psychiatry 44: 235-242.
18. Hockey RGJ. Maule JA. Clough PJ. Bdzola L. (2000) Effects of negative mood states on risk in everyday decision making. Cogn Emot 14: 823-855.
19. Isen AM. Geva N. (1987) The influence of positive affect on acceptable level of risk and thoughts about losing: The person with a large canoe has a large worry. Organ Behav Hum Decis Process 39: 145-154.
20. Kahneman D. Tversky A. (1979) Prospect theory: an analysis of decision under risk. Econometrica 47: 263-292.
21. Kodas E. Galineau L. Bodard S. Vancassel S. Guilloteau D. Besnard J. (2004) Serotonergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. J Neurochem 89: 695-702.
22. Lin P-Y. Su K-P. (2007) A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68: 1056-1061.
23. McLean A. Rubinsztein JS. Robbins TW. Sahakian BJ. (2004) The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression. Psychopharmacology 171: 286-297.
24. McNair DM. Lorr M. Droppelamn LF. (1971) Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service.
25. Merens W. Booij L. Markus RC. Zitman FG. Onkenhout W. Van der Does AJW. (2005) The effects of a tryptophan-enriched diet on mood and cortisol response in unmedicated recovered depressed patients and controls. Br J Nutr 94: 415-422.
26. Merens W. Van der Does AJW. Spinhoven P. (2007) The effects of serotonin manipulations on emotional information processing and mood. J Affect Disord 103: 43-62.
27. Murphy FC. Smith KA. Cowen PJ. Robbins TW. Sahakian BJ. (2002) The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology 163: 42-53.
28. Parker G. Gibson NA. Brotchie H. Heruc G. Rees A. Hadzi-Pavlovic D. (2006) Omega-3 fatty acids and mood disorders. Am J Psychiatry 163: 969-978.
29. Riedel WJ. Klaasen T. Deutz EPN. van Someren A. van Praag HM. (1999) Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology 141: 362-369.
30. Rogers RD. Lancaster M. Wakeley J. Bhagwagar Z. (2004) Effects of beta-adrenoceptor blockade on components of human-decision making. Psychopharmacology 172: 157-164.
31. Rogers RD. Tunbridge EM. Bhagwagar Z. Drevets WC. Sahakian BJ. Carter CS. (2003) Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 28: 153-162.
32. Rogers RD. Wakeley J. Robson PJ. Bhagwagar Z. Makela P. (2007) The effects of low doses of delta-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults. Neuropsychopharmacology 32: 417-428.
33. Saan RJ. Deelman BG. (1986) Nieuwe 15-woorden test A en B (15WTA en 15WTB) [New version of 15 Words Test (15WTA and 15WTB)]. In: Bauma, A, Mulder, J, Lindeboom, J, (eds). Neuro-Psychologische Diagnostiek: Handboek [Neuro-psychological Diagnostics: Handbook]. Lisse: Swets & Zeitlinger Publishers. pp. 13-28.
34. Scarna A. McTavish SFB. Cowen PJ. Goodwin GM. Rogers RD. (2005) The effects of a branched chain amino acid mixture supplemented with tryptophan on biochemical indices of neurotransmitter function and decision making. Psychopharmacology 179: 761-768.
35. Schmitt J. Jorissen B. Sobczak S. van Boxtel MPJ. Hogervorst E. Deutz NEP. (2000) Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers. Psychopharmacology 14: 21-29.
36. Schneider SL. Lopes LL. (1986) Reflection in preference under risk: who and when may suggest why. J Exp Psychol Hum Percept Perform 12: 535-548.
37. Sheehan DV. Lecrubier Y. Harnett-Sheehan K. Amorim P. Janavs J. Weiller E. (1998) The Mini International Neuropsychiatric Interview (M.I.N.I.). the development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry 59: 22-33.
38. Van der Does AJW. (2002a) Cognitive reactivity to sad mood: structure and validity of a new measure. Behav Res Ther 40: 105-120.
39. Van der Does AJW. (2002b) Handleiding bij de Nederlandse bewerking van de BDI-II. San Antonio, Texas/Amsterdam, The Netherlands: The Psychological Corporation/Harcourt Publishers.
40. http://www. dousa.nl/publications
41. Wald FDM. Mellenbergh GJ. (1990) De verkorte versie van de Nederlandse vertaling van de Profile of Mood States (POMS). Ned Tijdschr Psychol 45: 86-90.
42. Wood RM. Rilling JK. Sanfey AG. Bhagwagar Z. Rogers RD. (2006) Effects of tryptophan depletion on the performance of an iterated Prisoner's Dilemma game in healthy adults. Neuropsychopharmacology 31: 1075-1084.
43. Yehuda S. Rabinovitz S. Mostofsky DI. (1999) Essential fatty acids are mediators of brain biochemistry and cognitive functions. J Neurosci Res 56: 565-570.
44. Young G. Conquer J. (2005) Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev 45: 1-28.